- What we do
-
-
Routes of delivery
- Oral
- Nasal
- Pulmonary
- Parenteral
-
Development stage
- Pre-clinical
- Phase I to Phase II
- Phase III - Commercial
Our Approach
- Project Management
-
- About us
-
-
A CDMO like no other
- About Us
- Our Facilities
- Our History
- Awards and Achievements
-
Leadership Expertise
- Executive Leadership Team
- Board of Directors
- Careers
-
-
- Resources
- Events
- Contact
We are experts in oral, nasal and pulmonary delivery – able to support you to Phase I quickly or help you transition into Phase II and scale up to Phase III.
Meet our Executive Leaders, Nikki Whitfield (CEO), Richard Johnson (CSO) and Ian Lafferty (CTO), at DCAT Week to discover more about how we can bring success to your drug development journey.
Official DCAT Meeting Space
The Lexington Hotel, 511 Lexington Avenue (at 48th Street), New York, NY 10017.
A message from our CEO
Discover more about our integrated CDMO services and expertise in oral, nasal and pulmonary dosage forms.

Meet our experts

Nikki Whitfield
Chief Executive Officer

Dr. Richard Johnson
Chief Scientific Officer & Founder

Dr. Ian Lafferty
Chief Technical Officer

Laura Mason
Director of Pharmaceutical Sciences

Paul Kelsall
Director of Clinical Manufacturing

Helen Gisby
Director of Analytical Services

Matt Chillman
Principal Scientist
Meeting Space

Suite 1802
The Lexington Hotel
511 Lexington Avenue, (at 48th Street) New York, NY 10017
Request a meeting
Connect with our experts at DCAT Week and request a meeting to learn more about our integrated CDMO services.